Recombinant Human IL-31 protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg2222
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human IL-31 protein Ser24-Thr164 (Accession# Q6EBC2) with a rabbit IgG Fc tag at the N-terminus. |
GeneID | 386653 |
Accession | Q6EBC2 |
PredictedSize | 43.0 kDa |
SDS-PAGE | 42-55 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Interleukin-31 (IL-31) is a newly discovered four-helix bundle cytokine and expressed by several types of cells under both normal and disease state, such as activated CD4+T cells, mast cells, monocytes, macrophages, immature and mature monocyte-derived dendritic cells and so on. IL-31 signals through a heterodimeric receptor complex consisting of the IL31 receptor alpha (IL31Rα) and the oncostatin M receptor (OSMR). IL-31 plays a predominant function in the mediation of inflammatory and lymphoma-associated itch. Increased IL-31 expression has been detected in inflamed tissues from patients with atopic dermatitis, bowel diseases, allergic asthma and rhinitis.
References:
1. Zhang Q. et al. (2008) Cytokine Growth Factor Rev. 19:347-56. 2. Dillon SR. et al.(2004) Nat Immunol. 5:752-60. 3. Sonkoly E. et al. (2006) J Allergy Clin Immunol. 117: 411-417. 4. Bilsborough J. et al. (2006) J Allergy Clin Immunol. 117: 418-425. 5. Raap U.et al. (2008) J Allergy Clin Immunol. 122: 421-423.